{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:59:54Z","timestamp":1776959994769,"version":"3.51.4"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T00:00:00Z","timestamp":1133740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T00:00:00Z","timestamp":1133740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00415-005-0008-8","type":"journal-article","created":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T13:14:03Z","timestamp":1133788443000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Tic disorders: from pathophysiology to treatment"],"prefix":"10.1007","volume":"253","author":[{"given":"L.","family":"Rampello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alvano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Raffaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,12,5]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00702-004-0173-4","volume":"111","author":"Adams","year":"2004","unstructured":"Adams JR, Troiano AR, Calne DB (2004) Functional imaging in Tourette\u2019s syndrome. J Neural Transm 111:1495\u20131506","journal-title":"J Neural Transm"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.WNL.0000076181.39162.FC","volume":"61","author":"Albin","year":"2003","unstructured":"Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA (2003) Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 61:310\u2013315","journal-title":"Neurology"},{"key":"8_CR3","first-page":"75","volume":"267","author":"Allen","year":"1997","unstructured":"Allen AJ (1997) Group streptococcal infections and childhood neuropsychiatric disorder. Curr Opin 267:75","journal-title":"Curr Opin"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4088\/JCP.v65n0417","volume":"65","author":"Almeras","year":"2004","unstructured":"Almeras N, Despres JP, Villeneuve J, Demers MF, Roy MA, Cadrin C, Mottard JP, Bouchard RH (2004) Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry 65:557\u2013564","journal-title":"J Clin Psychiatry"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0733-8619(05)70319-4","volume":"15","author":"Alsobrook","year":"1997","unstructured":"Alsobrook JP, Pauls DL (1997) The genetics of Tourette syndrome. Neurol Clin 15:381\u2013893","journal-title":"Neurol Clin"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hup.537","volume":"18","author":"Amann","year":"2003","unstructured":"Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U (2003) EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18:641\u2013646","journal-title":"Hum Psychopharmacol"},{"key":"8_CR7","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Assn 103"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/01.WNL.0000123111.00324.BF","volume":"62","author":"Anca","year":"2004","unstructured":"Anca MH, Giladi N, Korczyn AD (2004) Ropinirole in Gilles de la Tourette syndrome. Neurology 62:1626\u20131627","journal-title":"Neurology"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/mds.20385","volume":"20","author":"Awaad","year":"2005","unstructured":"Awaad Y, Michon AM, Minarik S (2005) Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 20:714\u2013718","journal-title":"Mov Disord"},{"key":"8_CR10","first-page":"2263","volume":"59","author":"Bagheri","year":"1999","unstructured":"Bagheri MM, Kerbeshian J, Burd L (1999) Recognition and management of Tourette\u2019s syndrome and tic disorders. Am Fam Physician 59:2263\u20132272","journal-title":"Am Fam Physician"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1440-1614.2005.01549.x","volume":"39","author":"Begum","year":"2005","unstructured":"Begum M (2005) Clozapine\u2013induced stuttering, facial tics and myoclonic seizures: a case report. Aust N Z J Psychiatry 39:202","journal-title":"Aust N Z J Psychiatry"},{"key":"8_CR12","unstructured":"Black KJ (2002) Tourette Syndrome and Other Tic Disorders Available from: http:\/\/www. eMedicine. com"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/1531-8257(200011)15:6<1194::AID-MDS1019>3.0.CO;2-H","volume":"15","author":"Black","year":"2000","unstructured":"Black KJ, Mink JW (2000) Response to levodopa challenge in Tourette syndrome. Mov Disord 15:1194\u20131198","journal-title":"Mov Disord"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1176\/ajp.156.7.1122a","volume":"156","author":"Bonnier","year":"1999","unstructured":"Bonnier C, Nassogne M, Evrard P (1999) Ketanserin Treatment of Tourette\u2019s Syndrome in Children. Am J Psychiatry 156:1122\u20131123","journal-title":"Am J Psychiatry"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4088\/JCP.v62n0111","volume":"62","author":"Bruggeman","year":"2001","unstructured":"Bruggeman R, van der Linden C, Buitelaar JK (2001) Risperidone versus pimozide in Tourette\u2019s disorder: a comparative double\u2013blind parallelgroup study. J Clin Psychiatry 62:50\u201356","journal-title":"J Clin Psychiatry"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0005-7916(96)00002-X","volume":"27","author":"Carr","year":"1996","unstructured":"Carr JE, Bailey JS (1996) A brief behavior therapy protocol for Tourette syndrome. J Behav Ther Exp Psychiatry 27:33\u201340","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1440-1819.2004.01267.x","volume":"58","author":"Chang","year":"2004","unstructured":"Chang HL, Tu MJ, Wang HS (2004) Tourette\u2019s syndrome: psychopathology in adolescents. Psychiatry Clin Neurosci 58:353\u2013358","journal-title":"Psychiatry Clin Neurosci"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00004583-199509000-00010","volume":"34","author":"Chappell","year":"1995","unstructured":"Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attentiondeficit hyperactivity disorder and Tourette\u2019s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34:1140\u20131146","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR19","unstructured":"Cohen DJ, Jankovic J, Goetz CG (2001) Tourette syndrome. In: Advances in Neurology. Philadelphia, Pa: Lippincott Williams and Wilkins"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00439-003-0942-4","volume":"113","author":"Crawford","year":"2003","unstructured":"Crawford FC, Ait\u2013Ghezala G, Morris M, Sutcliffe MJ, Hauser RA, Silver AA, Mullan MJ (2003) Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 113:154\u2013161","journal-title":"Hum Genet"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajmg.a.30066","volume":"130","author":"Cuker","year":"2004","unstructured":"Cuker A, State MW, King RA, Davis N, Ward DC (2004) Candidate locus for Gilles de la Tourette syndrome\/obsessive compulsive disorder\/chronic tic disorder at 18q 22.Am J Med Genet 130:37\u201339","journal-title":"Am J Med Genet"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ana.410380405","volume":"38","author":"Demirkiran","year":"1995","unstructured":"Demirkiran M, Jankovic J (1995) Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 38:571\u2013579","journal-title":"Ann Neurol"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00041444-199909000-00007","volume":"9","author":"Devor","year":"1999","unstructured":"Devor EJ, Magee HJ (1999) Multiple childhood behavioral disorders (Tourette syndrome, multiple tics, ADD, and OCD) presenting in a family with a balanced chromosome translocation (t1; 8)(q21. 1;q22. 1). Psychiatr Genet 9:149\u2013151","journal-title":"Psychiatr Genet"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","volume":"22","author":"Dion","year":"2002","unstructured":"Dion Y, Annable L, Sandor P, Chouinard G (2002) Risperidone in the treatment of tourette syndrome: a double\u2013blind, placebo\u2013controlled trial. J Clin Psychopharmacol 22:31\u201339","journal-title":"J Clin Psychopharmacol"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1192\/bjp.162.5.593","volume":"162","author":"Eapen","year":"1993","unstructured":"Eapen V, Pauls DL, Robertson MM (1993) Evidence for autosomal dominant transmission in Tourette syndrome. Br J Psychiatry 162:593\u2013596","journal-title":"Br J Psychiatry"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0272-7358(99)00044-6","volume":"21","author":"Eichstedt","year":"2001","unstructured":"Eichstedt JA, Arnold SL (2001) Childhood\u2013 onset obsessive\u2013compulsive disorder: a tic\u2013related subtype of OCD? Clin Psychol Rev 21:137\u2013157","journal-title":"Clin Psychol Rev"},{"key":"8_CR27","first-page":"5","volume":"108","author":"Evidente","year":"2000","unstructured":"Evidente VG (2000) Is it a tic or Tourette\u2019s? Clues for differentiating simple from more complex tic disorders. Postgraduate Medicine 108:5","journal-title":"Postgraduate Medicine"},{"key":"8_CR28","first-page":"125","volume":"49","author":"Fahn","year":"1988","unstructured":"Fahn S (1988) Blepharospasm: a form of focal dystonia. Adv Neurol 49:125\u2013133","journal-title":"Adv Neurol"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pscychresns.2005.02.001","volume":"138","author":"Fattapposta","year":"2005","unstructured":"Fattapposta F, Restuccia R, Colonnese C, Labruna L, Garreffa G, Bianco F (2005) Gilles de la Tourette syndrome and voluntary movement: a functional MRI study. Psychiatry Res 138:269\u2013272","journal-title":"Psychiatry Res"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1345\/aph.1D497","volume":"38","author":"Fountoulakis","year":"2004","unstructured":"Fountoulakis KN, Iacovides A, St Kaprinis G (2004) Successful treatment of Tourette\u2019s disorder with amisulpride. Ann Pharmacother 38:90","journal-title":"Ann Pharmacother"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.58.1.85","volume":"58","author":"Fredericksen","year":"2002","unstructured":"Fredericksen KA, Cutting LE, Kates WR, Mostofsky SH, Singer HS, Cooper KL, et al. (2002) Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 58:85\u201389","journal-title":"Neurology"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","volume":"41","author":"Gaffney","year":"2002","unstructured":"Gaffney Gr, Perry PJ, Lund BC, Bever\u2013 Stille KA, Arndt S, Kuperman S (2002) Risperidone versus clonidine in the treatment of children and adolescents with Tourette\u2019s syndrome. J Am Acad Child Adolesc Psychiatry 41:330\u2013336","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1176\/ajp.156.8.1270","volume":"156","author":"Gaulin","year":"1999","unstructured":"Gaulin BD, Markowitz JS, Caley CF, Nesbitt LA, Dufresne RL (1999) Clozapine\u2013 Associated Elevation in Serum Triglycerides. Am J Psychiatry 156:1270\u20131272","journal-title":"Am J Psychiatry"},{"key":"8_CR34","first-page":"385","volume":"57","author":"Gazdag","year":"2004","unstructured":"Gazdag G, Barna I, Ivanyi Z, Tolna J (2004) The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz 57:385\u2013390","journal-title":"Ideggyogy Sz"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1345\/aph.17302","volume":"32","author":"Gerber","year":"1998","unstructured":"Gerber PE, Lynd LD (1998) Selective serotonin\u2013reuptake inhibitor\u2013induced movement disorders. Ann Pharmacother 32:692\u2013698","journal-title":"Ann Pharmacother"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004583-200402000-00017","volume":"43","author":"Gilbert","year":"2004","unstructured":"Gilbert DL, Batterson JR, Sethuraman G, Sallee FR (2004) Tic reduction with risperidone versus pimozide in a randomized, double\u2013blind, crossover trial. J Am Acad Child Adolesc Psychiatry 43:206\u2013214","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/01.WNL.0000044058.64647.7E","volume":"60","author":"Gilbert","year":"2003","unstructured":"Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR (2003) Tic reduction with pergolide in a randomized controlled trial in children. Neurology 60:606\u2013611","journal-title":"Neurology"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.biopsych.2005.02.022","volume":"57","author":"Gilbert","year":"2005","unstructured":"Gilbert DL, Sallee FR, Zhang J, Lipps TD, Wassermann EM (2005) Transcranial Magnetic Stimulation\u2013Evoked Cortical Inhibition: A Consistent Marker of Attention\u2013Deficit\/Hyperactivity Disorder Scores in Tourette Syndrome. Biol Psychiatry 57:1597\u20131600","journal-title":"Biol Psychiatry"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","volume":"54","author":"Gilbert","year":"2000","unstructured":"Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR (2000) Tourette\u2019s syndrome improvement with pergolide in a randomized, double\u2013blind, crossover trial. Neurology 54:1310\u20131315","journal-title":"Neurology"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mds.1068","volume":"16","author":"Goetz","year":"2001","unstructured":"Goetz CG, Chmura TA, Lanska DJ (2001) History of tic disorders and Gilles de La Tourette syndrome: Part 5 of the MDS\u2013sponsored history of movement disorders exhibit, Barcelona. Mov Disord 16:346\u2013349","journal-title":"Mov Disord"},{"key":"8_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0896-6273(00)00113-6","volume":"28","author":"Graybiel","year":"2000","unstructured":"Graybiel AM, Rauch SL (2000) Toward a neurobiology of obsessivecompulsive disorder. Neuron 28:343\u2013347","journal-title":"Neuron"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0165-5728(00)00320-9","volume":"111","author":"Hallett","year":"2000","unstructured":"Hallett JJ, Harling\u2013Berg CJ, Knopf PM, Stopa EG, Kiessling LS (2000) Antistriatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 111:195\u2013202","journal-title":"J Neuroimmunol"},{"key":"8_CR43","first-page":"237","volume":"85","author":"Hallett","year":"2001","unstructured":"Hallett M (2001) Neurophysiology of tics. Adv Neurol 85:237\u2013244","journal-title":"Adv Neurol"},{"key":"8_CR44","first-page":"311","volume":"85","author":"Hamilton","year":"2001","unstructured":"Hamilton CS, Garvey MA, Swedo SE (2001) Therapeutic implications of immunology for tics and obsessivecompulsive disorder. Adv Neurol 85:311\u2013318","journal-title":"Adv Neurol"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/WNL.53.4.813","volume":"53","author":"Hanna","year":"1999","unstructured":"Hanna PA, Janjua FN, Contant CF (1999) Bilineal transmission in Tourette syndrome. Neurology 53:813\u2013818","journal-title":"Neurology"},{"key":"8_CR46","unstructured":"Hanna PA, Jankovic J (2002) Sleep and tic disorders. In: Chokroverty S, Hening Walters A (eds) Sleep and movement disorders. Woburn, Mass Butterworth\u2013Heinemann, pp 181\u2013189"},{"key":"8_CR47","unstructured":"Hoekstra PJ, Anderson GM, Limburgc PC, Korfd J, Kallenbergc CGM, Minderaa RB (2004) Neurobiology and neuroimmunology of Tourette\u2019s syndrome: an update"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/1469-7610.00802","volume":"42","author":"Hornsey","year":"2001","unstructured":"Hornsey H, Banerjee S, Zeitlin H, Robertson M (2001) The prevalence of Tourette syndrome in 13\u201314\u2013year\u2013olds in mainstream schools. J Child Psycol Psychiatry 42:1035\u20131039","journal-title":"J Child Psycol Psychiatry"},{"key":"8_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/cap.1995.5.215","volume":"5","author":"Horrigan","year":"1995","unstructured":"Horrigan JP, Barnhill LJ (1995) Guanfacine for treatment of attentiondeficit hyperactivity disorder in boys. J Child Adolesc Psychopharmacol 5:215\u2013223","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"8_CR50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004583-199501000-00013","volume":"34","author":"Hunt","year":"1995","unstructured":"Hunt RD, Arnsten AFT, Asbell MD (1995) An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50\u201354","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.42.3.652","volume":"42","author":"Hyde","year":"1992","unstructured":"Hyde TM, Aaronson BA, Randolph C, Rickler KC, Weinberger DR (1992) Relationship of birth weight to the phenotypic expression of Gilles de la Tourette\u2019s syndrome in monozygotic twins. Neurology 42:652\u2013658","journal-title":"Neurology"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0733-8619(05)70311-X","volume":"15","author":"Jankovic","year":"1997","unstructured":"Jankovic J (1997) Tourette syndrome: phenomenology and classification of tics. Neurol Clin 15:267\u2013275","journal-title":"Neurol Clin"},{"key":"8_CR53","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMra010032","volume":"345","author":"Jankovic","year":"2001","unstructured":"Jankovic J (2001) Tourette\u2019s syndrome. N Engl J Med 345:1184\u20131192","journal-title":"N Engl J Med"},{"key":"8_CR54","first-page":"15","volume":"85","author":"Jankovic","year":"2001","unstructured":"Jankovic J (2001) Differential diagnosis and etiology of tics. Adv Neurol 85:15\u201329","journal-title":"Adv Neurol"},{"key":"8_CR55","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2165\/00003495-200161150-00005","volume":"61","author":"Jimenez\u2013Jimenez","year":"2001","unstructured":"Jimenez\u2013Jimenez FJ, Garcia\u2013Ruiz PJ (2001) Pharmacological options for treatment of Tourette\u2019s disorder. Drugs 61:2207\u20132220","journal-title":"Drugs"},{"key":"8_CR56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0925-4927(02)00066-5","volume":"116","author":"Kates","year":"2002","unstructured":"Kates WR, Frederikse M, Mostofsky SH, Folley BS, Cooper K, Mazur\u2013Hopkins P, Kofman O, Singer HS, Denckla MB, Pearlson GD, Kaufmann WE (2002) MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res 116:63\u201381","journal-title":"Psychiatry Res"},{"key":"8_CR57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/peds.92.1.39","volume":"92","author":"Kiessling","year":"1993","unstructured":"Kiessling LS, Marcotte AC, Culpepper L (1993) Antineuronal antibodies in movement disorders. Pediatrics 92:39\u201343","journal-title":"Pediatrics"},{"key":"8_CR58","first-page":"79","volume":"85","author":"King","year":"2001","unstructured":"King RA, Scahill L (2001) Emotional and behavioral difficulties associated with Tourette syndrome. Adv Neurol 85:79\u201388","journal-title":"Adv Neurol"},{"key":"8_CR59","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/00004583-199909000-00026","volume":"38","author":"Kofoed","year":"1999","unstructured":"Kofoed L, Tadepalli G, Oesterheld JR, Awadallah S, Shapiro R (1999) Case series: clonidine has no systematic effects on PR or QTc intervals in children. J Am Acad Child Adolesc Psychiatry 38:1193\u20131196","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00128072-200103050-00004","volume":"3","author":"Kossoff","year":"2001","unstructured":"Kossoff EH, Singer HS (2001) Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs 3:355\u2013363","journal-title":"Paediatr Drugs"},{"key":"8_CR61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0733-8619(05)70315-7","volume":"15","author":"Kumar","year":"1997","unstructured":"Kumar R, Lang AE (1997) Tourette syndrome. Secondary tic disorders. Neurol Clin 15:309\u2013331","journal-title":"Neurol Clin"},{"key":"8_CR62","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1212\/WNL.39.5.731","volume":"39","author":"Kurlan","year":"1989","unstructured":"Kurlan K, Lichter D, Hewitt D (1989) Sensory tics in Tourette\u2019s Syndrome. Neurology 39:731\u2013734","journal-title":"Neurology"},{"key":"8_CR63","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.59.3.414","volume":"59","author":"Kurlan","year":"2002","unstructured":"Kurlan R, Como PG, Miller B (2002) The behavioural spectrum of tic disorders: a community\u2013based study. Neurology 59:414\u2013420","journal-title":"Neurology"},{"key":"8_CR64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0733-8619(05)70321-2","volume":"15","author":"Kurlan","year":"1997","unstructured":"Kurlan R (1997) Tourette syndrome. Treatment of tics. Neurol Clin 15:403\u2013409","journal-title":"Neurol Clin"},{"key":"8_CR65","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1212\/WNL.50.6.1530","volume":"50","author":"Kurlan","year":"1998","unstructured":"Kurlan R (1998) Tourette\u2019s syndrome and \u2018PANDAS\u2019:Will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Neurology 50:1530\u20131534","journal-title":"Neurology"},{"key":"8_CR66","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/mds.10618","volume":"18","author":"Kwak","year":"2003","unstructured":"Kwak C, Dat VK, Jankovic J (2003) Premonitory sensory phenomenon in Tourette\u2019s syndrome. Mov Disord 18:1530\u20131533","journal-title":"Mov Disord"},{"key":"8_CR67","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/archneur.60.11.1595","volume":"60","author":"Kwak","year":"2003","unstructured":"Kwak C, Vuong KD, Jankovic J (2003) Migraine headache in patients with Tourette syndrome. Arch Neurol 60:1595\u20131598","journal-title":"Arch Neurol"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archneur.57.8.1190","volume":"57","author":"Kwak","year":"2000","unstructured":"Kwak CH, Hanna PA, Jankovic J (2000) Botulinum toxin in the treatment of tics. Arch Neurol 57:1190\u20131193","journal-title":"Arch Neurol"},{"key":"8_CR69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.41.2_Part_1.223","volume":"41","author":"Lang","year":"1991","unstructured":"Lang AE (1991) Patient perception of tics and other movement disorders. Neurology 41:223\u2013228","journal-title":"Neurology"},{"key":"8_CR70","first-page":"355","volume":"85","author":"Lang","year":"2001","unstructured":"Lang AE (2001) Update on the treatment of tics. Adv Neurol 85:355\u2013362","journal-title":"Adv Neurol"},{"key":"8_CR71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1024170622266","volume":"74","author":"Lebovitz","year":"2003","unstructured":"Lebovitz HE (2003) Metabolic consequences of atypical antipsychotic drugs. Psychiatr Q Fall 74:277\u2013290","journal-title":"Psychiatr Q Fall"},{"key":"8_CR72","unstructured":"Leckman JF, Cohen DJ (1988) Descriptive and diagnostic classification of tic disorders. In: Cohen DJ, Bruun RD, Leckman JF (eds) Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, NY: John Wiley and Sons, pp 3\u201321"},{"key":"8_CR73","first-page":"John","volume":"York","author":"Leckman","year":"1999","unstructured":"Leckman JF, Cohen DJ (1999) Tourette\u2019s syndrome\u2013Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. New York: John Wiley and Sons","journal-title":"New"},{"key":"8_CR74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00004583-199003000-00010","volume":"29","author":"Leckman","year":"1990","unstructured":"Leckman JF, Dolnansky ES, Hardin MT, Clubb M, Walkup JT, Stevenson J, et al. (1990) Perinatal factors in the expression of Tourette\u2019s syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry 29:220\u2013226","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR75","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","volume":"48","author":"Leckman","year":"1991","unstructured":"Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ (1991) Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48:324\u2013328","journal-title":"Arch Gen Psychiatry"},{"key":"8_CR76","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","volume":"57","author":"Leckman","year":"2005","unstructured":"Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA (2005) Increased serum levels of interleukin\u201312 and tumor necrosis factor\u2013alpha in Tourette\u2019s syndrome. Biol Psychiatry 57:667\u2013673","journal-title":"Biol Psychiatry"},{"key":"8_CR77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1469-7610.1997.tb01508.x","volume":"38","author":"Leckman","year":"1997","unstructured":"Leckman JF, Peterson BDS, Anderson GM, Arnsten ATF, Pauls DL, Cohen DJ (1997) Pathogenesis of Tourette\u2019s syndrome. J Child Psychol Psychiatry 38:119\u2013142","journal-title":"J Child Psychol Psychiatry"},{"key":"8_CR78","first-page":"1","volume":"85","author":"Leckman","year":"2001","unstructured":"Leckman JF, Peterson BS, King RA (2001) Phenomenology of tics and natural history of tic disorders. Adv Neurol 85:1\u201314","journal-title":"Adv Neurol"},{"key":"8_CR79","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0193-953X(05)70348-8","volume":"20","author":"Leckman","year":"1997","unstructured":"Leckman JF, Peterson BS, Pauls DL, Cohen DJ (1997) Tic disorders. Psychiatr Clin North Am 20:839\u2013861","journal-title":"Psychiatr Clin North Am"},{"key":"8_CR80","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0896-6273(00)00114-8","volume":"28","author":"Leckman","year":"2000","unstructured":"Leckman JF, Riddle MA (2000) Tourette's syndrome: when habitforming systems form habits of their own? Neuron 28:349\u2013354","journal-title":"Neuron"},{"key":"8_CR81","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1176\/ajp.150.1.98","volume":"150","author":"Leckman","year":"1993","unstructured":"Leckman JF, Walker DE, Cohen DJ (1993) Premonitory urges in Tourette's syndrome. Am J Psychiatry 150:98\u2013102","journal-title":"Am J Psychiatry"},{"key":"8_CR82","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/mds.20100","volume":"19","author":"Lesperance","year":"2004","unstructured":"Lesperance P, Djerroud N, Diaz Anzaldua A, Rouleau GA, Chouinard S, Richer F;Montreal Tourette Study Group (2004) Restless legs in Tourette syndrome. Mov Disord 19:1084\u20131087","journal-title":"Mov Disord"},{"key":"8_CR83","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0733-8619(05)70043-8","volume":"19","author":"Marcus","year":"2001","unstructured":"Marcus D, Kurlan R (2001) Tics and its disorders. Neurol Clin 19:735\u2013758","journal-title":"Neurol Clin"},{"key":"8_CR84","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","volume":"56","author":"Marras","year":"2001","unstructured":"Marras C, Andrews D, Sime E, Lang AE (2001) Botulinum toxin for simple motor tics: a randomized, doubleblind, controlled clinical trial. Neurology 56:605\u2013610","journal-title":"Neurology"},{"key":"8_CR85","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/303093","volume":"67","author":"Merette","year":"2000","unstructured":"Merette C, Brassard A, Potvin A, Bouvier H, Rousseau F, Emond C, et al. (2000) Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 67:1008\u20131013","journal-title":"Am J Hum Genet"},{"key":"8_CR86","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/archneur.60.10.1365","volume":"60","author":"Mink","year":"2003","unstructured":"Mink JW (2003) The basal ganglia and involuntary movements. Arch Neurol 60:1365\u20131368","journal-title":"Arch Neurol"},{"key":"8_CR87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0301-0082(96)00042-1","volume":"50","author":"Mink","year":"1996","unstructured":"Mink JW (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381\u2013425","journal-title":"Prog Neurobiol"},{"key":"8_CR88","first-page":"113","volume":"85","author":"Mink","year":"2001","unstructured":"Mink JW (2001) Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns? Adv Neurol 85:113\u2013122","journal-title":"Adv Neurol"},{"key":"8_CR89","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0006-3223(01)01096-4","volume":"50","author":"Morshed","year":"2001","unstructured":"Morshed SA, Parveen S, Leckman JF (2001) Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette\u2019s syndrome, Sydenham\u2019s chorea, and autoimmune disorders. Biol Psychiatry 50:566\u2013577","journal-title":"Biol Psychiatry"},{"key":"8_CR90","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/104454603322572624","volume":"13","author":"Mukaddes","year":"2003","unstructured":"Mukaddes NM, Abali O (2003) Quetiapine treatment of children and adolescents with Tourette\u2019s disorder. J Child Adolesc Psychopharmacol 13:295\u2013299","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"8_CR91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-1781(00)00125-6","volume":"94","author":"Mullen","year":"2000","unstructured":"Mullen N, Riedel M, Straube A, Gunther W, Wilske B (2000) Increased anti\u2013streptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res 94:43\u201349","journal-title":"Psychiatry Res"},{"key":"8_CR92","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1163\/1568560042342338","volume":"12","author":"Muller","year":"2004","unstructured":"Muller N (2004) Anti\u2013inflammatory therapy with a COX\u20132 inhibitor in Tourette's syndrome. Inflammopharmacology 12:271\u2013275","journal-title":"Inflammopharmacology"},{"key":"8_CR93","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.psychres.2004.04.009","volume":"129","author":"Muller","year":"2004","unstructured":"Muller N, Riedel M, Blendinger C, Oberle K, Jacobs E, Abele\u2013Horn M (2004) Mycoplasma pneumoniae infection and Tourette's syndrome. Psychiatry Res 129:119\u2013125","journal-title":"Psychiatry Res"},{"key":"8_CR94","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1517\/14656566.3.7.899","volume":"3","author":"Muller\u2013Vahl","year":"2002","unstructured":"Muller\u2013Vahl KR (2002) The treatment of Tourette\u2019s syndrome: current opinions. Expert Opin Pharmacother 3:899\u2013914","journal-title":"Expert Opin Pharmacother"},{"key":"8_CR95","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1517\/14656566.4.10.1717","volume":"4","author":"Muller\u2013Vahl","year":"2003","unstructured":"Muller\u2013Vahl KR (2003) Cannabinoids reduce symptoms of Tourette's syndrome. Expert Opin Pharmacother 4:1717\u20131725","journal-title":"Expert Opin Pharmacother"},{"key":"8_CR96","first-page":"23","volume":"6","author":"Muller\u2013Vahl","year":"1999","unstructured":"Muller\u2013Vahl KR, Kolbe H, Schneider U (1999) Cannabis in movement disorders. Forsch Komplementarmed 6:23\u201327","journal-title":"Forsch Komplementarmed"},{"key":"8_CR97","doi-asserted-by":"crossref","unstructured":"Muller\u2013Vahl KR, Meyer GJ, Knapp WH, Emrich HM, Gielow P, Brucke T, Berding G (2005) Serotonin transporter binding in Tourette Syndrome. Neurosci Lett (Epub ahead of print)","DOI":"10.1016\/j.neulet.2005.05.031"},{"key":"8_CR98","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.npp.1300047","volume":"28","author":"Muller\u2013Vahl","year":"2003","unstructured":"Muller\u2013Vahl KR, Prevedel H, Theloe K, Kolbe H, Emrich HM, Schneider U (2003) Treatment of Tourette syndrome with delta\u20139\u2013tetrahydrocannabinol (delta 9\u2013THC): no influence on neuropsychological performance. Neuropsychopharmacology 28:384\u2013388","journal-title":"Neuropsychopharmacology"},{"key":"8_CR99","first-page":"1","volume":"28","author":"Murphy","year":"2005","unstructured":"Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M (2005) Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 28:1\u20132","journal-title":"Int J Neuropsychopharmacol"},{"key":"8_CR100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/ajp.154.3.402","volume":"154","author":"Murphy","year":"1997","unstructured":"Murphy TK, Goodman WK, Fudge MW (1997) B lymphocyte antigen D8\/17: a peripheral marker for childhood\u2013 onset obsessive\u2013compulsive disorder and Tourette's syndrome? Am J Psychiatry 154:402\u2013407","journal-title":"Am J Psychiatry"},{"key":"8_CR101","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0269881103017001714","volume":"17","author":"Niederhofer","year":"2003","unstructured":"Niederhofer H, Staffen W, Mair A (2003) A placebo\u2013controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. J Psychopharmacol 17:113\u2013119","journal-title":"J Psychopharmacol"},{"key":"8_CR102","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.mp.4001151","volume":"7","author":"Nordstrom","year":"2002","unstructured":"Nordstrom EJ, Burton FH (2002) A transgenic model of comorbid Tourette's syndrome and obsessivecompulsive disorder circuitry. Mol Psychiatry 7:524","journal-title":"Mol Psychiatry"},{"key":"8_CR103","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.305.5689.1390","volume":"305","author":"Olson","year":"2004","unstructured":"Olson S (2004) Neurobiology. Making sense of Tourette's. Science 305:1390\u20131392","journal-title":"Science"},{"key":"8_CR104","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s004150070173","volume":"247","author":"Onofrj","year":"2000","unstructured":"Onofrj M, Paci G, D'Andrea M, Toma L (2000) Olanzapine in severe Gilles de la Tourette syndrome: a 52\u2013week double\u2013blind cross\u2013over study vs. low\u2013dose pimozide. J Neurol 247:443\u2013446","journal-title":"J Neurol"},{"key":"8_CR105","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/brain\/awh473","volume":"128","author":"Orth","year":"2005","unstructured":"Orth M, Amann B, Robertson MM, Rothwell JC (2005) Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain 128:292\u20131300","journal-title":"Brain"},{"key":"8_CR106","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.CHI.0000046854.56865.DE","volume":"42","author":"Parraga","year":"2003","unstructured":"Parraga HC, Parraga MI, Woodward RL, Fenning PA (2003) Quetiapine treatment of children with Tourette's syndrome: report of two cases. J Am Acad Child Adolesc Psychiatry 42:623\u2013624","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR107","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1086\/424389","volume":"75","author":"Paschou","year":"2004","unstructured":"Paschou P, Feng Y, Pakstis AJ, Speed WC, DeMille MM, Kidd JR, Jaghori B, Kurlan R, Pauls DL, Sandor P, Barr CL, Kidd KK (2004) Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region. Am J Hum Genet 75:545\u2013560","journal-title":"Am J Hum Genet"},{"key":"8_CR108","first-page":"281","volume":"85","author":"Pauls","year":"2001","unstructured":"Pauls DL (2001) Update on the genetics of Tourette syndrome. Adv Neurol 85:281\u2013293","journal-title":"Adv Neurol"},{"key":"8_CR109","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0022-3999(02)00586-X","volume":"55","author":"Pauls","year":"2003","unstructured":"Pauls DL (2003) An update on the genetics of Gilles de la Tourette syndrome. J Psychosom Res 55:7\u201312","journal-title":"J Psychosom Res"},{"key":"8_CR110","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1176\/ajp.155.11.1592","volume":"155","author":"Perlmutter","year":"1998","unstructured":"Perlmutter SJ, Garvey MA, Castellanos X, Mittleman BB, Giedd J, Rapoport JL, Swedo SE (1998) A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 155:1592\u20131598","journal-title":"Am J Psychiatry"},{"key":"8_CR111","unstructured":"Perry P, Gaffney G Pediatric Psychopharmacology: Tourette's Syndrome. Clinical Psychopharmacology Seminar 1996 Peer Review. Available from: http:\/\/www. vh. org\/Providers\/ Conferences\/CPS\/42. html 4"},{"key":"8_CR112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0005-7967(92)90140-C","volume":"30","author":"Peterson","year":"1992","unstructured":"Peterson AL, Azrin NH (1992) An evaluation of behavioral treatments for Tourette syndrome. Behav Res Ther 30:167\u2013174","journal-title":"Behav Res Ther"},{"key":"8_CR113","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.60.4.415","volume":"60","author":"Peterson","year":"2003","unstructured":"Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang H, Bronen R, King RA, Leckman JF, Staib L (2003) Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 60:415\u2013424","journal-title":"Arch Gen Psychiatry"},{"key":"8_CR114","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1176\/appi.ajp.161.11.2028","volume":"161","author":"Plessen","year":"2004","unstructured":"Plessen KJ, Wentzel\u2013Larsen T, Hugdahl K, Feineigle P, Klein J, Staib LH, Leckman JF, Bansal R, Peterson BS (2004) Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry 161:2028\u20132037","journal-title":"Am J Psychiatry"},{"key":"8_CR115","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1055\/s-2004-832690","volume":"37","author":"Pogarell","year":"2004","unstructured":"Pogarell O, Juckel G, Mulert C, Amann B, M\u00f6ller HJ, Heger U (2004) EEG Abnormalities Under Treatment with Atypical Antipsychotics: Effects of Olanzapine and Amisulpride as Compared to Haloperidol. Pharmacopsychiatry 37:304\u2013305","journal-title":"Pharmacopsychiatry"},{"key":"8_CR116","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s10072-003-0201-4","volume":"24","author":"Porta","year":"2004","unstructured":"Porta M, Maggioni G, Ottaviani F, Schindler A (2004) Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A Neurol Sci 24:420\u2013423","journal-title":"Neurol Sci"},{"key":"8_CR117","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/1044546041649084","volume":"14","author":"Posey","year":"2004","unstructured":"Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ (2004) Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 14:233\u2013241","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"8_CR118","first-page":"97","volume":"21","author":"Poyurovsky","year":"1998","unstructured":"Poyurovsky M, Bergman Y, Shoshani D, Schneidman M, Weizman A (1998) Emergence of obsessive\u2013compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol 21:97\u2013100","journal-title":"Clin Neuropharmacol"},{"key":"8_CR119","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1388-2457(03)00359-6","volume":"115","author":"Raffaele","year":"2004","unstructured":"Raffaele R, Vecchio I, Alvano A, Proto G, Nicoletti G, Rampello L (2004) Blink reflex abnormalities in Tourette sindrome. Clin Neurophysiol 115:320\u2013324","journal-title":"Clin Neurophysiol"},{"key":"8_CR120","first-page":"88","volume":"242","author":"Rampello","year":"1995","unstructured":"Rampello L, Nicoletti G, Vecchio I (1995) Clinical and evolutive aspects of Tourette's syndrome. J Neurol 242:88","journal-title":"J Neurol"},{"key":"8_CR121","first-page":"248","volume":"15","author":"Rampello","year":"2000","unstructured":"Rampello L, Vecchio I, Furnari P (2000) Tourette's sindrome: phenotipic and aetiopathogenetic spectrum. Mov Disord 15:248","journal-title":"Mov Disord"},{"key":"8_CR122","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","volume":"123","author":"Robertson","year":"2000","unstructured":"Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123:425\u2013462","journal-title":"Brain"},{"key":"8_CR123","unstructured":"Rothenberger A, Kostanecka T, Kinkelbur J, Cohrs S, Woerner W, Hajak G (2001) Sleep and Tourette syndrome. In: Cohen DJ, Jankovic J, Goetz CG (eds) Tourette syndrome. Vol 85 of Advances in neurology. Philadelphia: Lippincott Williams and Wilkins, pp 245\u2013259"},{"key":"8_CR124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1024\/\/1422-4917.28.2.105","volume":"28","author":"Ruth","year":"2000","unstructured":"Ruth U, Mayer\u2013Rosa J, Schlamp D, Freisleder FJ (2000) Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine. Z Kinder Jugendpsychiatr Psychother 28:105\u2013108","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"key":"8_CR125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","volume":"39","author":"Sallee","year":"2000","unstructured":"Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB (2000) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 39:292\u2013299","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8_CR126","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","volume":"154","author":"Sallee","year":"1997","unstructured":"Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G (1997) Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 154:1057\u20131062","journal-title":"Am J Psychiatry"},{"key":"8_CR127","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","volume":"158","author":"Scahill","year":"2001","unstructured":"Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF (2001) A Placebo\u2013Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder. Am J Psychiatry 158:1067\u20131074","journal-title":"Am J Psychiatry"},{"key":"8_CR128","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","volume":"60","author":"Scahill","year":"2003","unstructured":"Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS (2003) A placebo\u2013controlled trial of risperidone in Tourette syndrome. Neurology 60:1130\u20131135","journal-title":"Neurology"},{"key":"8_CR129","first-page":"261","volume":"85","author":"Tanner","year":"2001","unstructured":"T L, Tanner C, Dure L (2001) The epidemiology of tics and Tourette syndrome in children and adolescents. Adv Neurol 85:261\u2013271","journal-title":"Adv Neurol"},{"key":"8_CR130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awh318","volume":"128","author":"Serrien","year":"2005","unstructured":"Serrien DJ, Orth M, Evans AH, Lees AJ, Brown P (2005) Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence. Brain 128:116\u2013125","journal-title":"Brain"},{"key":"8_CR131","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","volume":"46","author":"Shapiro","year":"1989","unstructured":"Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA (1989) Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 46:722\u2013730","journal-title":"Arch Gen Psychiatry"},{"key":"8_CR132","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1517\/14728214.10.2.365","volume":"10","author":"Silay","year":"2005","unstructured":"Silay YS, Jankovic J (2005) Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs 10:365\u2013380","journal-title":"Expert Opin Emerg Drugs"},{"key":"8_CR133","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4088\/JCP.v62n0908","volume":"62","author":"Silver","year":"2001","unstructured":"Silver AA, Shytle RD, Philipp MK (2001) Transdermal nicotine and haloperidol in Tourette's disorder: a double\u2013blind placebo\u2013contolled study. J Clin Psychiatry 62:707\u2013714","journal-title":"J Clin Psychiatry"},{"key":"8_CR134","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ajmg.1192","volume":"105","author":"Simonic","year":"2001","unstructured":"Simonic I, Nyholt DR, Gericke, GS, Gordon D, Matsumoto N, Ledbetter DH, Ott J, Weber JL (2001) Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11, 8q22, and 11q23\u201324 in South African Afrikaners. Am J Med Genet 105:163\u2013167","journal-title":"Am J Med Genet"},{"key":"8_CR135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0006-3223(95)94542-5","volume":"37","author":"Singer","year":"1995","unstructured":"Singer HS (1995) Neurobiology of Tourette syndrome Biol Psychiatry 37:629","journal-title":"Biol Psychiatry"},{"key":"8_CR136","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L","volume":"15","author":"Singer","year":"2000","unstructured":"Singer HS (2000) Current issues in Tourette Syndrome. Mov Disord 15:1051\u20131063","journal-title":"Mov Disord"},{"key":"8_CR137","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(05)70018-1","volume":"4","author":"Singer","year":"2005","unstructured":"Singer HS (2005) Tourette's syndrome: from behaviour to biology. Lancet Neurol 4:149\u2013159","journal-title":"Lancet Neurol"},{"key":"8_CR138","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/WNL.50.6.1618","volume":"50","author":"Singer","year":"1998","unstructured":"Singer HS, Giuliano JD, Hansen BH, Hallett JJ, Laurino JP, Benson M, Kiessling LS (1998) Antibodies against human putamen in children with Tourette syndrome. Neurology 50:1618\u20131624","journal-title":"Neurology"},{"key":"8_CR139","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0006-3223(98)00384-9","volume":"46","author":"Singer","year":"1999","unstructured":"Singer HS, Giuliano JD, Hansen BH, et al. (1999) Antibodies against a neuron\u2013like (HTB10 neuroblastoma) cell in children with Tourette syndrome. Biol Psychiatry 46:775\u2013780","journal-title":"Biol Psychiatry"},{"key":"8_CR140","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.870120518","volume":"12","author":"Singer","year":"1997","unstructured":"Singer HS, Krumholz A, Giuliano J, Kiessling LS (1997) Antiphospholipid antibodies: an epiphenomenon in Tourette syndrome. Mov Disord 12:738\u2013742","journal-title":"Mov Disord"},{"key":"8_CR141","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.clinph.2003.12.027","volume":"115","author":"Smith","year":"2004","unstructured":"Smith JL, Johnstone SJ, Barry RJ (2004) Inhibitory processing during the Go\/NoGo task: an ERP analysis of children with attention\u2013deficit\/hyperactivity disorder. Clin Neurophysiol 115:1320\u20131331","journal-title":"Clin Neurophysiol"},{"key":"8_CR142","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/jnnp.52.7.895","volume":"52","author":"Smith","year":"1989","unstructured":"Smith SJ, Lees AJ (1989) Abnormalities of the blink reflex in Gilles de la Tourette syndrome. J Neurol Neurosurgery Psychiatry 52:895\u2013898","journal-title":"J Neurol Neurosurgery Psychiatry"},{"key":"8_CR143","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1073\/pnas.0730775100","volume":"100","author":"State","year":"2003","unstructured":"State MW, Greally JM, Cuker A, Bowers PN, Henegariu O, Morgan TM, et al. (2003) Epigenetic abnormalities associated with a chromosome 18(q21\u2013q22) inversion and a Gilles de la Tourette syndrome phenotype. Proc Natl Acad Sci USA 100:4684\u20134689","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR144","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(02)09620-4","volume":"360","author":"Stein","year":"2002","unstructured":"Stein DJ (2002) Obessive\u2013compulsive disorder. Lancet 360:397\u2013405","journal-title":"Lancet"},{"key":"8_CR145","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/1044546041648959","volume":"14","author":"Stephens","year":"2004","unstructured":"Stephens RJ, Bassel C, Sandor P (2004) Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome\u2013a pilot study. J Child Adolesc Psychopharmacol 14:255\u2013266","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"8_CR146","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/pgmj.2004.023614","volume":"81","author":"Stern","year":"2005","unstructured":"Stern JS, Burza S, Robertson MM (2005) Gilles de la Tourette's syndrome and its impact in the UK. Postgrad Med J 81:12\u201319","journal-title":"Postgrad Med J"},{"key":"8_CR147","first-page":"223","volume":"11","author":"Tatlipinar","year":"2001","unstructured":"Tatlipinar S, Iener EC, Ilhan B (2001) Ophtalmic manifestations of Gilles de la Tourette syndrome. Eur Ophtalmol 11:223\u2013226","journal-title":"Eur Ophtalmol"},{"key":"8_CR148","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mds.10649","volume":"19","author":"Temel","year":"2004","unstructured":"Temel Y, Visser\u2013Vandewalle V (2004) Surgery in Tourette syndrome. Mov Disord 19:3\u201314","journal-title":"Mov Disord"},{"key":"8_CR149","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/302613","volume":"65","author":"The","year":"1999","unstructured":"The Tourette Syndrome Association International Consortium for Genetics (1999) A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 65:1428\u20131436","journal-title":"Am J Hum Genet"},{"key":"8_CR150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneur.1993.00540100012008","volume":"50","author":"The","year":"1993","unstructured":"The Tourette Syndrome Classification Study Group (1993) Definitions and classification of tic disorders. Arch Neurol 50:1013\u20131016","journal-title":"Arch Neurol"},{"key":"8_CR151","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2850.1995.tb00062.x","volume":"2","author":"Tolchard","year":"1995","unstructured":"Tolchard B (1995) Treatment of Gilles de la Tourette syndrome using behavioural psychotherapy: a single case example. J Psychiatr Ment Health Nurs 2:233\u2013236","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"8_CR152","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0006-3223(94)90051-5","volume":"35","author":"Toren","year":"1994","unstructured":"Toren P, Toren A, Weizman A, Mozes T, Eldar S, Magor A, Mandel M, Rechavi G, Many A, Mester R (1994) Tourette's disorder: is there an association with the antiphospholipid syndrome? Biol Psychiatry 35:495\u2013498","journal-title":"Biol Psychiatry"},{"key":"8_CR153","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4088\/JCP.v66n0413","volume":"66","author":"Toren","year":"2005","unstructured":"Toren P, Weizman A, Ratner S, Cohen D, Laor N (2005) Ondansetron treatment in Tourette's disorder: a 3\u2013week, randomized, double\u2013blind, placebocontrolled study. J Clin Psychiatry 66:499\u2013503","journal-title":"J Clin Psychiatry"},{"key":"8_CR154","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","volume":"58","author":"Tourette's","year":"2002","unstructured":"Tourette's Syndrome Study Group (2002) Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527\u2013536","journal-title":"Neurology"},{"key":"8_CR155","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0140-6736(98)05964-9","volume":"353","author":"Vandewalle","year":"1999","unstructured":"Vandewalle V, van der Linden C, Groenewegen HJ (1999) Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 353:724","journal-title":"Lancet"},{"key":"8_CR156","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0005-7967(03)00154-2","volume":"42","author":"Verdellen","year":"2004","unstructured":"Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA (2004) Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther 42:501\u2013511","journal-title":"Behav Res Ther"},{"key":"8_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0888-7543(03)00097-1","volume":"82","author":"Verkerk","year":"2003","unstructured":"Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA, and the Tourette Syndrome Association International Consortium for Genetics (2003) CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82:1\u20139","journal-title":"Genomics"},{"key":"8_CR158","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/jama.292.8.909","volume":"292","author":"Voelker","year":"2004","unstructured":"Voelker R (2004) Scientists use neuroimaging, genetic studies to probe biology of tourette syndrome. JAMA 292:909\u2013911","journal-title":"JAMA"},{"key":"8_CR159","first-page":"684","volume":"59","author":"Walkup","year":"1996","unstructured":"Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O (1996) Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 59:684\u2013693","journal-title":"Am J Hum Genet"},{"key":"8_CR160","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1176\/appi.ajp.160.6.1175","volume":"160","author":"Wilhelm","year":"2003","unstructured":"Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L (2003) Habit Reversal Versus Supportive Psychotherapy for Tourette's Disorder: A Randomized Controlled Trial. Am J Psychiatry 160:1175\u20131177","journal-title":"Am J Psychiatry"},{"key":"8_CR161","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","volume":"273","author":"Wolf","year":"1996","unstructured":"Wolf SS, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM, et al. (1996) Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273:1225\u20131227","journal-title":"Science"},{"key":"8_CR162","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1901\/jaba.2003.36-109","volume":"36","author":"Woods","year":"2003","unstructured":"Woods DW, Twohig MP, Flessner CA, Roloff TJ (2003) Treatment of vocal tics in children with Tourette syndrome: investigating the efficacy of habit reversal. J Appl Behav Anal 36:109\u2013112","journal-title":"J Appl Behav Anal"},{"key":"8_CR163","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1086\/339520","volume":"70","author":"Zhang","year":"2002","unstructured":"Zhang H, Leckman JF, Pauls DL, Tsai CP, Kidd KK, Campos MR (2002) Genome wide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet 70:896\u2013904","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-005-0008-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0008-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T19:06:32Z","timestamp":1683313592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-005-0008-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,5]]},"references-count":163,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-0008-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,5]]},"assertion":[{"value":"24 April 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}